In-111 transferrin scintigraphy in cirrhosis with hypoalbuminemia: Evidence for protein-losing enteropathy in a small group of selected cases

References

• Faybik P, Hertz H. Plasma disappearance rate of indocyanine green in liver dysfunction. Transplantation Proc 2006;38:801–2.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Watanabe G. Hepatic parenchymal cell volume and the indocyanin green tolerance test. J Surg Res 2000;92:222–7.
   PubMed Web of Science ®Google Scholar
• Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, Prognostic value of the Galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J Hepatol 1996;25:474–80.
   PubMed Web of Science ®Google Scholar
• Pauwels S, Geubel A, Dive C, Beckers C. Breath 14CO2 after intravenous administration of [14C]Aminopyrine in liver diseases. Dig Dis Sci 1982;27:49–56.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Ishii Y, Asai S, Kohno T, Mazaki T, Takahashi Y, [1-13C] test of galactose and fructose for quantitative liver function. J Surg Res 2001;96:90–5.
   PubMedGoogle Scholar
• Baruqye SL, Razquin M, Jimenez I, Vazquez A, Gisbert JP, Pajares JM. 13C-Phenylalanine and 13C-Methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Digest Liver Dis 2000;32:226–32.
   Google Scholar
• Davcev P, Vanovski B. Protein-losing enteropathy in patients with liver cirrhosis. Digestion 1969;2:17–22.
   PubMedGoogle Scholar
• Georgopoulos P, Mowat C, McMilla DC, Kingstone K, Ghosh S, Stanley AJ. Is portal hypertension associated with protein-losing enteropathy? J Gastroenterol Hepatol 2005;20:103–7.
   PubMedGoogle Scholar
• Stanley AJ, Gilmour HM, Ghosh S, Fergusson A, McGilchrist AJ. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology 1996;111:2679–1682.
   Google Scholar
• Alkhouri N, Carter-Kent C, Mayacy S, Hupertz V, Eghtesad B, Quintini C, Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis. Liver Transpl 2009;15:1894–6.
   PubMedGoogle Scholar
• Conn HO. Comment. Am J Gastroenterol 1998;93:127–8.
   PubMedGoogle Scholar
• Quigley EM, Ross IN, Haeney MR, Holbrook IB, Marsh MN. Reassessment of faecal α1-antitrypsin excretion for use as screening test for intestinal protein loss. J Clin Pathol 1987;40:60–6.
   Google Scholar
• Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-Losing enteropathy: diagnosis with 99m human serum albumin scintigraphy. Radiology 2001;219:86–90.
   PubMed Web of Science ®Google Scholar
• Kallel F, Amouri A, Hamza F, Charfeddine S, Guermazi F. Apport de la scintigraphie à l’albumine marquée dans les entéropathies exsudatives: à propos de deux cas. Méd Nucléaire 2009;33:671–3.
   Google Scholar
• Meristoudis G, Birbilis V, Ilias I, Tsaroucha A, Batsaki C, Christakopoulou K. Intestinal accumulation of 99m Tc-MDP in a patient with protein-losing enteropathy. Eur J Med Mol. Imaging 1999;35:224.
   Google Scholar
• Simonsen JA, Braad PE, Veje A, Gerke O, Schaffalitzky de Muckadelle OB, Flemming Hoilund-Carlsen P. 111Indium-transferrin for localization and quantification of gastrointestinal protein loss. Scand J Gastroenterol 2009;6:1–7.
   Google Scholar
• Kaiski MC, Peters AM, Bradley D, Hodgson HJ. Detection and quantification of protein-losing enteropathy with indium-111 transferrin. Eur J Nucl Med 1996;23:530–3.
   PubMedGoogle Scholar
• Saverymuttu SH, Peters AM, Lavender JP, Hodgson HJ. Detection of protein-losing enteropathy by 111In-Transferrin scanning. Eur J Nucl Med 1983;8:40–1.
   PubMedGoogle Scholar
• Aburano T, Yokoyama K, Kinuya S, Takayama T, Tonami N, Hisida K, Indium-111 transferrin imaging for the diagnosis of protein-losing enteropathy. Clin Nucl Med 1989;14:681–5.
   PubMedGoogle Scholar
• Berry CR, Fisher P, Koblik PD, Guilford WG, Hornof WH. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs. Am J Vet Res 1997;58:1188–92.
   PubMedGoogle Scholar
• Berry CR, Guilford WG, Koblik PD, Hornof WH, Fisher P. Scintigraphic evaluation of four dogs with protein-losing enteropathy using 111indium-labeled transferrin. Vet Radiol Ultrasound 1997;38:221–5.
   PubMedGoogle Scholar
• Farahat K, Hainaut P, Jamar F, Haot J, Lambert M. Lymphocytic gastritis: an unusual cause of hypoproteinaemia. J Intern Med 1993;234:95–100.
   PubMedGoogle Scholar
• ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP 2008;38:1–197.
   PubMedGoogle Scholar
• Aburano T, Yokoyama K, Kinuya S, Shuke N, Takayama T, Tonami N, The diagnostic value of In-111 transferrin imaging in protein-losing gastroenteropathy. Kaku Igaku 1991;28:11–17.
   PubMedGoogle Scholar
• Wong J, Sin NC, Syng R, Lee PSF, Lai PBS. Budd-Chiari induced protein-losing enteropathy after liver transplantation. Transplantation Proc 2007;39:1554–7.
   PubMedGoogle Scholar
• Dousset B, Legmann P, Soubrane O, Chaussade S, Couturier D, Houssin D, Protein-losing enteropathy secondary to hepatic venous outflow obstruction after liver transplantation. 1997;27:206–10.
   Google Scholar
• Meroni E, Malesci A, Spinelli P, Tommasini MA, Markert R, Bhutani MS. Observation of thoracic duct morphology in portal hypertension by endoscopic ultrasound. Gastrointest Endosc 1998;48:588–92.
   PubMedGoogle Scholar
• Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JH. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report. J Korean Med Sci 2004;19:466–9.
   PubMed Web of Science ®Google Scholar
• Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology 2003;38:258–66.
   PubMed Web of Science ®Google Scholar